Published in Scand J Infect Dis on January 01, 1999
Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am J Physiol Heart Circ Physiol (2008) 0.97
Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection. BMC Infect Dis (2008) 0.85
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients. BMC Infect Dis (2002) 0.76
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet (1998) 3.76
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature (1977) 2.58
Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol (2001) 2.43
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature (1981) 2.10
A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev (1979) 1.91
Persistence of immunogenicity of two complex antigens retained in vivo. Immunology (1968) 1.87
Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg (2001) 1.87
Computerization of undergraduate medical curriculum content. Med Educ (1984) 1.80
When allogeneic mouse spleen cells are mixed in vitro the T-cells secrete a product which guides the maturation of B-cells. Scand J Immunol (1972) 1.73
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Thymus-dependent and thymus-independent effector functions of mouse lymphoid cells. Comparison of cytotoxicity and primary antibody formation in vitro. Cell Immunol (1973) 1.55
A live human B-cell activator operating in isolation of other cellular influences. Scand J Immunol (1979) 1.54
Cyclosporin A--usefulness, risks and mechanism of action. Immunol Rev (1982) 1.50
Regulation of antibody synthesis against Escherichia coli endotoxin. IV. Induction of paralysis in vitro by treating normal lymphoid cells with antigen. J Exp Med (1969) 1.50
No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay. Immunology (1979) 1.39
T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun (1999) 1.38
Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1991) 1.37
Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today (1999) 1.31
Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet (1999) 1.31
T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Eur J Immunol (1989) 1.28
Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol (2005) 1.26
A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents. Infect Immun (2000) 1.24
Immunogenicity of human serum albumin: decay in the normal mouse. Immunology (1968) 1.23
Regulation of antibody synthesis against Escherichia coli endotoxin. II. Specificity, dose requirements and duration of paralysis induced in adult mice. Immunology (1969) 1.22
Antigenic competition in vitro between heterologous erythrocytes. Eur J Immunol (1972) 1.20
Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol (2001) 1.20
Spontaneous production of interferon-gamma in adult and newborn humans. J Immunol (1984) 1.20
Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut (1991) 1.19
Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol (2005) 1.18
Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease. Acta Chir Scand (1983) 1.14
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg (2005) 1.14
Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology (2001) 1.13
Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy. Scand J Immunol (1988) 1.08
Influence of fasting on intestinal permeability and disease activity in patients with rheumatoid arthritis. Scand J Rheumatol (1982) 1.08
Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control. J Exp Med (1975) 1.07
Local production of nitric oxide in patients with tuberculosis. Int J Tuberc Lung Dis (2004) 1.06
Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. J Infect Dis (1986) 1.06
HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS (1999) 1.06
Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection (1987) 1.05
Decrease in thymidylate kinase activity in peripheral blood mononuclear cells from HIV-infected individuals. Biochem Pharmacol (1998) 1.05
Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals. Clin Exp Immunol (1990) 1.05
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study. Pharmacogenomics J (2011) 1.04
Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression. J Immunol (1988) 1.03
Brugia pahangi: depressed mitogen reactivity in filarial infections in the jird, Meriones unguiculatus. Exp Parasitol (1976) 1.03
Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. Eur J Clin Microbiol Infect Dis (2009) 1.03
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J (2003) 1.03
Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets. Nephron (1990) 1.03
Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences. Scand J Immunol (1987) 1.02
Helminthes could influence the outcome of vaccines against TB in the tropics. Parasite Immunol (2006) 1.02
Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy (1984) 1.01
Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen. J Exp Med (1983) 1.01
Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res Hum Retroviruses (1995) 1.01
Growth-retarding mechanisms against lymphatic tumours. Search in mice and men. Transplant Rev (1971) 1.00
Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients. East Afr Med J (1999) 0.99
Modulation of polymorphonuclear leukocyte chemiluminescent response to the chemoattractant f-Met-Leu-Phe. Int Arch Allergy Appl Immunol (1982) 0.99
Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells. J Exp Med (1973) 0.98
Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun (1999) 0.97
Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis--a randomised trial. Tuberculosis (Edinb) (2011) 0.97
Secretion of gamma-interferon at the cellular level. Induction by Epstein-Barr virus. Scand J Immunol (1984) 0.97
Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma. J Infect Dis (1997) 0.97
Evidence for the ontogenic precedence of suppressor T cell functions in the human neonate. Eur J Immunol (1983) 0.97
Regulation of antibody synthesis against Escherichia coli endotoxin. 3. Induction of immunological paralysis in non-immune and pre-immunized mice. Immunology (1969) 0.97
Characteristics of the phagocytic process assessed by Coulter Counter. Acta Pathol Microbiol Scand C (1977) 0.97
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients. Pharmacogenomics J (2012) 0.96
Monocyte function in infectious mononucleosis: evidence for a reversible cellular defect. J Infect Dis (1976) 0.96
Mechanical manipulation of bone and cartilage cells with 'optical tweezers'. FEBS Lett (1999) 0.95
HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS (2000) 0.94
Endogenous nitric oxide in MDCK-I cells modulates the Vibrio cholerae haemagglutinin/protease (HA/P)-mediated cytotoxicity. Microb Pathog (1998) 0.93
Cellular mechanisms of restricted immunoglobulin formation in the human neonate. Eur J Immunol (1980) 0.93
Persistent productive HIV infection in EBV-transformed B lymphocytes. J Med Virol (1989) 0.93
Acyclovir treatment in infectious mononucleosis: a clinical and virological study. Infection (1987) 0.93
Emerging Leishmania/HIV co-infection in Africa. Med Microbiol Immunol (2001) 0.92
Analysis of the antigenic profile of Mycobacterium leprae: cross-reactive and unique specificities of human and rabbit antibodies. Scand J Immunol (1987) 0.92
Intestinal permeability to inert sugars and different-sized polyethyleneglycols in children with celiac disease. J Pediatr Gastroenterol Nutr (1989) 0.91
Chest physiotherapy in primary pneumonia. Br Med J (Clin Res Ed) (1985) 0.90
The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection (1985) 0.90
Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scand J Infect Dis (1998) 0.90
Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia. Clin Exp Immunol (1993) 0.90
Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis. Parasite Immunol (1990) 0.90
The interactive seminar: an educational approach for voluntary HIV testing in a drug dependence treatment unit. J Prof Nurs (1995) 0.90
Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand J Infect Dis (1986) 0.87
Intestinal permeability assessed with polyethylene glycols in children with diarrhea due to rotavirus and common bacterial pathogens in a developing community. J Pediatr Gastroenterol Nutr (1989) 0.87
Expression of inducible nitric oxide synthase and nitrotyrosine in borderline leprosy lesions. Br J Dermatol (2001) 0.86
Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte. Clin Exp Immunol (1981) 0.86
The immunological hazard of Cushing's syndrome. Br Med J (1975) 0.86
Gastrointestinal permeability in atopic and non-atopic mothers, assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy (1985) 0.86
Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis. Clin Exp Immunol (2001) 0.85
The nosocomial component of medical care. A prospective study on the amount, spectrum and costs of medical disturbances in a department of infectious diseases. Scand J Infect Dis Suppl (1982) 0.85
Unmasking and functional characterization of T-cell-replacing factors obtained from supernatants of allogeneic spleen cell mixtures. Scand J Immunol (1974) 0.85
Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains. Arch Virol (1993) 0.85